Specialty Pharmacy

Mole rats are remarkably resistant to cancer.

UM-164 blocks the c-Src kinase that plays a role in the growth and spread of breast cancer.

Positive relationship found between the pricing of HCV drug regimens with the rate of sustained viral response.

The evolocumab (Repatha) Pushtronex system is the first to offer a monthly single-dose delivery option.

Sutent is an oral multi-kinase inhibitor originally approved by the FDA in 2006.

Josh Stein, CEO and co-founder of AdhereTech, discusses how technology can enhance the ability of specialty pharmacies to manage their patients' therapy regimen.

Study finds disparities in cancer survival independent of socioeconomic status.

CD40-antibody drugs could have enhanced anti-tumor activity.

Top news from across the health care landscape.

Specialty drugs accounted for nearly half of total drug spending from just 1.8% of total prescriptions filled.

Four major hepatitis genotypes kill more people than HIV, malaria, and tuberculosis.

Humulin R U-500 has been approved since 1994 for the treatment of diabetes, but a dedicated syringe did not previously exist.

Study reveals untapped potential of gene-editing tool.

Top news of the day from across the health care landscape.

Certain bacterial populations are increased or decreased in the presence of cancer.

A majority of patients with specific gene mutation will eventually relapse and die of treatment-resistant leukemia.

Syndros can be used to treat anorexia due to AIDS, and nausea and vomiting due to chemotherapy.

Treating modifiable risk factors could enhance breast cancer prevention.

Top articles of the week from The American Journal of Pharmacy Benefits.

Obstructive sleep apnea in MS patients can lead to deeper problems.

Anti-nausea and vomit medication could help reduce hospitalization in liver cancer.

Physicians caring for Medicaid patients will no longer receive payment bumps.

Antiretroviral therapy may alleviate some cognitive problems among HIV-positive patients.

Recent advances and updates in oncology and cancer drug development.

A more hands-on approach to patient care can improve overall outcomes.

MEDI4736 is an experimental human monoclonal antibody used against PDL1.

Adherence to a plant-based diet low in animal foods found to improve overall health.

Top news of the day from across the health care landscape.